# The Impact of Hyperuricemia on the Progression of Atherosclerotic Cardiovascular Disease

**Authors:** Marika Mdivnishvili, Maia Kharebashvili, Vakhtang Chumburidze, Kakha Nadaraia, Lali Gujejiani, Ketino Virkovi

PMC · DOI: 10.7759/cureus.94371 · Cureus · 2025-10-11

## TL;DR

This paper explores how high uric acid levels may worsen heart and blood vessel diseases, highlighting the need for early detection and treatment.

## Contribution

The paper emphasizes the clinical importance of asymptomatic hyperuricemia as a modifiable risk factor for cardiovascular disease.

## Key findings

- Hyperuricemia is linked to oxidative stress and inflammation, which may worsen atherosclerosis.
- Elevated uric acid levels are associated with increased cardiovascular mortality.
- Early detection and treatment of hyperuricemia could reduce cardiovascular risks.

## Abstract

Hyperuricemia refers to elevated levels of serum uric acid (SUA) beyond the normal physiological range in men and women. It is caused by increased endogenous synthesis, decreased renal clearance, or a combination. While hyperuricemia has long been associated with gout, new evidence suggests that it is a significant risk factor in the pathophysiology of a variety of cardiovascular and metabolic disorders, including hypertension, metabolic syndrome, coronary artery disease, heart failure, type 2 diabetes mellitus, and chronic kidney disease. The increasing global frequency of hyperuricemia has sparked scientific and clinical interest in the possible mechanistic relationship between elevated SUA levels and cardiovascular morbidity. Hyperuricemia's pathological mechanisms, including oxidative stress, endothelial dysfunction, and systemic inflammation, may lead to vascular remodeling, atherosclerotic plaque progression, and increased cardiovascular mortality.

This case report emphasizes the need for increased clinical awareness of the cardiovascular dangers associated with asymptomatic hyperuricemia. Its purpose is to investigate the potential link between elevated SUA and the severity of coronary artery involvement, emphasizing the importance of early detection and treatment of hyperuricemia as a modifiable cardiovascular risk factor.

## Linked entities

- **Diseases:** gout (MONDO:0005393), metabolic syndrome (MONDO:0000816), coronary artery disease (MONDO:0005010), heart failure (MONDO:0005252), type 2 diabetes mellitus (MONDO:0005148), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** type 2 diabetes mellitus (MESH:D003924), Hyperuricemia (MESH:D033461), heart failure (MESH:D006333), Atherosclerotic Cardiovascular Disease (MESH:D050197), chronic kidney disease (MESH:D051436), inflammation (MESH:D007249), gout (MESH:D006073), cardiovascular and metabolic disorders (MESH:D024821), hypertension (MESH:D006973), coronary artery disease (MESH:D003324)
- **Chemicals:** uric acid (MESH:D014527), SUA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12603437/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12603437/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12603437/full.md

---
Source: https://tomesphere.com/paper/PMC12603437